PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy. Ivanidze J, Gardella J, Olson A, Sun SM, et al. AJNR Am J Neuroradiol 2026 Apr 29:ajnr.A9387. doi: 10.3174/ajnr.A9387.

Read + Share

Amedeo Smart

Independent Medical Education